Pediatric Annals

LETTERS TO THE EDITOR 

Cefprozil Breakpoint

David E Domann, MS, RPh

Abstract

To the Editor:

I am writing concerning an article entitled *Cefprozil" (cefzil, Bristol Laboratories, Evansville, Indiana) by H.R. Stutman, MD [Pediatric Annals. 1993;20:167170]. In this article, the susceptibility breakpoint for cefprozil was incorrectly listed as "≤2 mg/L".

The susceptibility breakpoint for cefprozil, as determined by the National Committee for Clinical Laboratory Standards (NCCLS, 1990) is ≤8 mg/L.…

To the Editor:

I am writing concerning an article entitled *Cefprozil" (cefzil, Bristol Laboratories, Evansville, Indiana) by H.R. Stutman, MD [Pediatric Annals. 1993;20:167170]. In this article, the susceptibility breakpoint for cefprozil was incorrectly listed as "≤2 mg/L".

The susceptibility breakpoint for cefprozil, as determined by the National Committee for Clinical Laboratory Standards (NCCLS, 1990) is ≤8 mg/L.

10.3928/0090-4481-19931001-04

Sign up to receive

Journal E-contents